Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
13.16
+0.16 (1.23%)
Dec 23, 2024, 4:00 PM EST - Market closed
CRBP Employees
Corbus Pharmaceuticals Holdings had 19 employees as of December 31, 2023. The number of employees decreased by 14 or -42.42% compared to the previous year.
Employees
19
Change (1Y)
-14
Growth (1Y)
-42.42%
Revenue / Employee
n/a
Profits / Employee
-$2,036,859
Market Cap
160.28M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ModivCare | 21,200 |
Nutex Health | 800 |
Adaptimmune Therapeutics | 449 |
Sutro Biopharma | 302 |
Seres Therapeutics | 233 |
Cellectis | 221 |
Pro-Dex | 148 |
Nanobiotix | 102 |
CRBP News
- 14 days ago - Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB-601 to Treat Patients with Advanced Solid Tumors - GlobeNewsWire
- 20 days ago - FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer - GlobeNewsWire
- 6 weeks ago - Corbus Pharmaceuticals' Sell-Off: Speculative Entry Price In Oncology And Obesity Therapies - Seeking Alpha
- 7 weeks ago - Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference - GlobeNewsWire
- 2 months ago - Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (CRB-701) - GlobeNewsWire
- 3 months ago - Corbus Pharmaceuticals to Participate in the BMO Capital Markets' Oncology Summit - GlobeNewsWire
- 3 months ago - Nasdaq-Traded Cannabinoid Biotech Corbus Pharma Stock Plunges 60%, But Analysts Say 'Buy The Dip' Now - Benzinga
- 4 months ago - Obesity drugs' next wave: These companies could snag 20% of GLP-1 market, analysts say - Market Watch